Beximco Pharmaceuticals Limited (BXP.L) Stock Price

£46.5 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    5

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Beximco Pharmaceuticals Limited, AI stock picks, stock alerts and much more.

Sign up

BXP.L AI Stock Analysis

AI stock analysis for BXP.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Beximco Pharmaceuticals Limited (BXP.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Beximco Pharmaceuticals Limited (BXP.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Beximco Pharmaceuticals Limited (BXP.L), currently trading at £46.5, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About BXP.L

LSE

  • Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh.

  • Symbol

    BXP.L

  • Market

    LSE

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    207.4M

Similar Stocks

STX.L Shield Therapeutics
STX.L		 £7
9.7%
5
HLN.L Haleon plc
HLN.L		 £362.9
0.8%
6
HCM.L HUTCHMED (China) Limited
HCM.L		 £222
1.6%
4
HIK.L Hikma Pharmaceuticals PLC
HIK.L		 £1785
1.7%
7
EAH.L ECO Animal Health Group
EAH.L		 £73.5
0.2%
6

News

Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Above Fifty Day Moving Average – Here’s Why

Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Above Fifty Day Moving Average – Here’s Why
February 12, 2025. ETF Daily News
Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 200 Day Moving Average of $35.76

Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 200 Day Moving Average of $35.76
September 28, 2024. ETF Daily News
Beximco Pharmaceuticals (LON:BXP) Shares Pass Below Two Hundred Day Moving Average of $36.29

Beximco Pharmaceuticals (LON:BXP) Shares Pass Below Two Hundred Day Moving Average of $36.29
September 20, 2024. ETF Daily News
Beximco Pharmaceuticals (LON:BXP) Stock Price Up 9.5%

Beximco Pharmaceuticals (LON:BXP) Stock Price Up 9.5%
September 4, 2024. ETF Daily News

BXP.L Alternative Data

Web Traffic

Beximco Pharmaceuticals Limited receives an estimated 17129 monthly visitors to beximcopharma.com.

  • Web Traffic

    17129

  • Change from Previous Month

    70%

  • 3 Month Change

    52.7%

  • YoY Change

    52.7%

Twitter Followers

Beximco Pharmaceuticals Limited has 652 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    652

  • Daily Change

    0.2%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.8%

Facebook Engagement

Beximco Pharmaceuticals Limited has engaged 244 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    244

  • Daily Change

    58.4%

  • 1 Month Change

    97.4%

  • 3 Month Change

    88.6%

Youtube Subscribers

Beximco Pharmaceuticals Limited has 5,460 subscribers on its main Youtube channel, up by 1.1% over the last month.

  • Youtube Subscribers

    5460

  • Daily Change

    0%

  • 1 Month Change

    1.1%

  • 3 Month Change

    3.4%

Reddit Mentions

Beximco Pharmaceuticals Limited has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Beximco Pharmaceuticals Limited is 82 out of 100 (very bullish), down by -8.9% over the last month.

  • Business Outlook

    82

  • Change from Previous Month

    8.9%

  • 3 Month Change

    8.9%

  • YoY Change

    8.9%

LinkedIn Employees

According to LinkedIn, Beximco Pharmaceuticals Limited has 2,892 employees, up by 2.3% over the last month.

  • LinkedIn Employees

    2892

  • Daily Change

    2.3%

  • 1 Month Change

    2.3%

  • 3 Month Change

    4.6%

  • YoY Change

    4.6%

News Mentions

Beximco Pharmaceuticals Limited was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

BXP.L Financials

BXP.L Key Metrics

  • Total Revenue

    BDT12.3B

  • Net Income

    BDT1.8B

  • Earnings per Share

    BDT4.1

  • Free cash flow

    -BDT279.9M

  • EBITDA

    BDT2.6B

  • EBITDA Ratio

    0.211927

  • Total Assets

    BDT73.8B

BXP.L 2-year Revenue & Income
BXP.L 2-year Free Cash Flow

BXP.L Technicals

BXP.L SMA
BXP.L RSI

FAQ

What's the current price of Beximco Pharmaceuticals Limited (BXP.L) Stock?
The price of an Beximco Pharmaceuticals Limited (BXP.L) share is £46.5.

What's the market cap of Beximco Pharmaceuticals Limited?
The current market cap of Beximco Pharmaceuticals Limited is 207.4M.

Should I buy or sell BXP.L?
Beximco Pharmaceuticals Limited shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Beximco Pharmaceuticals Limited is better viewed as a hold or accumulate position while waiting for further developments.

Is Beximco Pharmaceuticals Limited a good investment?
The current analysis of Beximco Pharmaceuticals Limited's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Beximco Pharmaceuticals Limited's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Beximco Pharmaceuticals Limited (BXP.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Beximco Pharmaceuticals Limited stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Beximco Pharmaceuticals Limited (BXP.L) that investors often compare it to?
Beximco Pharmaceuticals Limited (BXP.L) is often compared to similar stocks such as Shield Therapeutics, Haleon plc, HUTCHMED (China) Limited, Hikma Pharmaceuticals PLC and ECO Animal Health Group.

What is the forecast for Beximco Pharmaceuticals Limited's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Beximco Pharmaceuticals Limited's stock price to be around £49.12 in 2026. Starting from the current price of £46.5, this represents a 5.6% change in price, indicating a bullish outlook for the stock.

How to buy Beximco Pharmaceuticals Limited (BXP.L) Stock?
Beximco Pharmaceuticals Limited stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Beximco Pharmaceuticals Limited shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.